Wednesday, 02 September 2015 13:54

Munich: iPS center CARE starts in 2017 Featured

In the following two years, the stem cell technology center "Center for Regenerative Engineering" (CARE) will be built in Munich. According to media reports, the Bavarian Economics Minister Ilse Aigner has pledged 15 million euros start-up funding to the stem cell researcher Prof. Hans Schöler to build up the Translation Centre. 

CARE combines modern stem cell technologies with the pharmaceutical research. With the help of iPS cells and disease models in the petri dish drugs can betested on a large scale. Therefore many animal experiments can be omitted.

In 2010, Prof. Hans Schöler, Director at the Max Planck Institute for Molecular Biomedicine, had already the prospect to get some million euros both from the land and the federal government for his plans of a stem cell research center in Münster, called CARE.

However, in October 2013 the state government of Nordrhine-Westphalia retracted its funding commitment on the ground, the legal and economic conditions for financing from state funds were not fulfilled in accordance with an expert opinion, reports Biotechnology, a science platform, which had been initiated in 2005 by the Federal Ministry of Education and Research (BMBF).

According to the report, the state government Bavaria has provided the project in the draft supplementary budget in 2016, on which the state parliament has to decide in autumn. Subsidies in a total amount of EUR 15 million should be anchored for three years. In January 2017 the Center will launch.